Comparison between EUS-guided fine-needle biopsy with or without rapid on-site evaluation for tissue sampling of solid pancreatic lesions: A systematic review and meta-analysis
Open Access
- 30 November 2022
- journal article
- review article
- Published by Wolters Kluwer Health in Endoscopic Ultrasound
- Vol. 11 (6) , 458-465
Abstract
The benefit of rapid on-site evaluation (ROSE) on the diagnostic accuracy of EUS–guided fine-needle biopsy (EUS-FNB) in patients with pancreatic masses is still matter of debate. Aim of our meta-analysis is to compare the diagnostic outcomes of these two tissue acquisition strategies. Computerized bibliographic search on the main databases was performed through December 2021 and 8 studies were identified (2147 patients). The primary outcome was sample adequacy. Pooled effects were terms of odds ratio (OR) or mean difference and 95% confidence Interval (CI). There was no difference in terms of baseline variables between the two groups. Pooled sample adequacy was 95.5% (95% CI 93.2%–97.8%) and 88.9% (83.4%-94.5%) in the EUS-FNB + ROSE and EUS-FNB groups, respectively (OR = 2.05, 0.94–4.49; P = 0.07). Diagnostic accuracy resulted significantly superior in the EUS-FNB + ROSE group (OR = 2.49, 1.08–5.73; P = 0.03), particularly when the analysis was restricted to reverse bevel needle (OR = 3.24, 1.19–8.82, P = 0.02), whereas no statistical difference was observed when newer end-cutting needles were used (OR = 0.71, 0.29–3.61, P = 0.56). Diagnostic sensitivity was not significantly different between the two groups (OR = 1.94, 0.84–4.49; P = 0.12), whereas pooled specificity was 100% with both approaches. The number of needle passes needed to obtain diagnostic samples was not significantly different (mean difference 0.07,-0.22 to 0.37; P = 0.62). Our meta-analysis stands for a non-superiority of EUS-FNB + ROSE over EUS-FNB with newer end-cutting needles, whereas ROSE could have still a role when reverse bevel needles are used.Keywords
This publication has 27 references indexed in Scilit:
- Comparison of Endoscopic Ultrasound–Fine-Needle Aspiration and Endoscopic Ultrasound–Fine-Needle Biopsy for Solid Lesions in a Multicenter, Randomized TrialClinical Gastroenterology and Hepatology, 2018
- AGA White Paper: Optimizing Endoscopic Ultrasound–Guided Tissue Acquisition and Future DirectionsClinical Gastroenterology and Hepatology, 2018
- Su1356 Sharkcore Pancreatic Biopsies With Rose (Rapid On-Site Evaluation) Have a Higher Diagnostic Yield Than Sharkcore Biopsies Without RoseGastrointestinal Endoscopy, 2017
- The presence of rapid on-site evaluation did not increase the adequacy and diagnostic accuracy of endoscopic ultrasound-guided tissue acquisition of solid pancreatic lesions with core needleSurgical Endoscopy, 2016
- The role of endoscopy in the evaluation and management of patients with solid pancreatic neoplasiaGastrointestinal Endoscopy, 2016
- Rapid on-site evaluation of endoscopic-ultrasound-guided fine-needle aspiration diagnosis of pancreatic massesWorld Journal of Gastroenterology, 2014
- Impact of rapid on‐site evaluation on the adequacy of endoscopic‐ultrasound guided fine‐needle aspiration of solid pancreatic lesions: A systematic review and meta‐analysisJournal of Gastroenterology and Hepatology, 2013
- GRADE guidelines: 7. Rating the quality of evidence—inconsistencyJournal of Clinical Epidemiology, 2011
- The Cochrane Collaboration's tool for assessing risk of bias in randomised trialsBMJ, 2011
- Meta-analysis in clinical trialsControlled Clinical Trials, 1986